Cite
Qadir AS, Guégan JP, Ginestier C, et al. CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells. iScience. 2021;24(11):103348doi: 10.1016/j.isci.2021.103348.
Qadir, A. S., Guégan, J. P., Ginestier, C., Chaibi, A., Bessede, A., Charafe-Jauffret, E., Macario, M., Lavoué, V., Rouge, T. M., Law, C., Vilker, J., Wang, H., Stroup, E., Schipma, M. J., Bridgeman, B., Murmann, A. E., Ji, Z., Legembre, P., & Peter, M. E. (2021). CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells. iScience, 24(11), 103348. https://doi.org/10.1016/j.isci.2021.103348
Qadir, Abdul S, et al. "CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells." iScience vol. 24,11 (2021): 103348. doi: https://doi.org/10.1016/j.isci.2021.103348
Qadir AS, Guégan JP, Ginestier C, Chaibi A, Bessede A, Charafe-Jauffret E, Macario M, Lavoué V, Rouge TM, Law C, Vilker J, Wang H, Stroup E, Schipma MJ, Bridgeman B, Murmann AE, Ji Z, Legembre P, Peter ME. CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells. iScience. 2021 Oct 29;24(11):103348. doi: 10.1016/j.isci.2021.103348. eCollection 2021 Nov 19. PMID: 34816102; PMCID: PMC8593563.
Copy
Download .nbib